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Abstract. 
 
While many cell types express receptors for 
the Fc domain of IgG (Fc
 
g
 
R), only primate polymor-
phonuclear neutrophils (PMN) express an Fc
 
g
 
R linked 
to the membrane via a glycan phosphoinositol (GPI) 
anchor. Previous studies have demonstrated that this 
GPI-linked Fc
 
g
 
R (Fc
 
g
 
RIIIB) cooperates with the 
transmembrane Fc
 
g
 
R (Fc
 
g
 
RIIA) to mediate many of 
the functional effects of immune complex binding. To 
determine the role of the GPI anchor in Fc
 
g
 
 receptor 
synergy, we have developed a model system in Jurkat T 
cells, which lack endogenously expressed Fc
 
g
 
 recep-
tors. Jurkat T cells were stably transfected with cDNA 
encoding Fc
 
g
 
RIIA and/or Fc
 
g
 
RIIIB. Cocrosslinking 
the two receptors produced a synergistic rise in intracy-
 
toplasmic calcium ([Ca
 
2
 
1
 
]
 
i
 
) to levels not reached by 
stimulation of either Fc
 
g
 
RIIA or Fc
 
g
 
RIIIB alone. Syn-
ergy was achieved by prolonged entry of extracellular 
Ca
 
2
 
1
 
. Cocrosslinking Fc
 
g
 
RIIA with CD59 or CD48, 
two other GPI-linked proteins on Jurkat T cells also led 
to a synergistic [Ca
 
2
 
1
 
]
 
i
 
 rise, as did crosslinking CD59 
with Fc
 
g
 
RIIA on PMN, suggesting that interactions be-
tween the extracellular domains of the two Fc
 
g
 
 recep-
tors are not required for synergy. Replacement of the 
GPI anchor of Fc
 
g
 
RIIIB with a transmembrane anchor 
abolished synergy. In addition, tyrosine to phenylala-
nine substitutions in the immunoreceptor tyrosine-
based activation motif (ITAM) of the Fc
 
g
 
RIIA cyto-
plasmic tail abolished synergy. While the ITAM of 
Fc
 
g
 
RIIA was required for the increase in [Ca
 
2
 
1
 
]
 
i
 
, ty-
rosine phosphorylation of crosslinked Fc
 
g
 
RIIA was di-
minished when cocrosslinked with Fc
 
g
 
RIIIB. These 
data demonstrate that Fc
 
g
 
RIIA association with 
GPI-linked proteins facilitates Fc
 
g
 
R signal transduc-
tion and suggest that this may be a physiologically sig-
nificant role for the unusual GPI-anchored Fc
 
g
 
R of hu-
man PMN.
 
T
 
he 
 
binding of immune complexes by polymorpho-
nuclear neutrophils (PMN)
 
1
 
 receptors for the Fc do-
main of IgG (Fc
 
g
 
 receptors) induces essential host
defense and inflammatory responses such as adhesion,
phagocytosis of antibody-coated microorganisms, degran-
ulation, and the respiratory burst (33, 38). PMN activation
by immune complexes is important in the pathology of
serum sickness, the Arthus reaction, acute glomerulone-
phritis, rheumatoid arthritis, and other idiopathic inflam-
matory disorders as well as in host defense against infec-
tion. The Fc
 
g
 
 receptors are a family of hematopoietic cell
receptors that share structurally related ligand-binding do-
mains for the Fc portion of immunoglobulins, but which
differ in their transmembrane and intracellular domains
(for review see 16, 33). These varying cytoplasmic tails pre-
sumably give rise to distinct intracellular signals to provide
diversity of function.
Primate PMN are unique, because in addition to the trans-
membrane Fc
 
g
 
R, Fc
 
g
 
RIIA, they express the only known
eukaryotic nontransmembrane Fc
 
g
 
R, the glycan phospho-
inositol (GPI)-linked Fc
 
g
 
RIIIB. Ligand binding by trans-
membrane Fc
 
g
 
RIIA initiates a tyrosine kinase cascade de-
pendent upon the cytoplasmic tail of this receptor, which
contains one copy of an immunoreceptor tyrosine-based
activation motif (ITAM) (11, 27), a substrate for phosphor-
ylation by members of the src tyrosine kinase family. The
phosphorylated ITAM of Fc
 
g
 
RIIA can bind to and acti-
vate syk tyrosine kinase, which subsequently activates a num-
ber of effector pathways (16). In contrast, little is known
about the signaling mechanisms of Fc
 
g
 
RIIIB, the most
abundant PMN Fc
 
g
 
 receptor. Some studies have suggested
an inability of Fc
 
g
 
RIIIB to transduce signals indepen-
dently. These studies, taken together with this receptor’s
lack of a cytoplasmic domain, have led to the concept that
Fc
 
g
 
RIIIB is primarily an Fc-binding molecule that aids in
immune complex presentation to Fc
 
g
 
RIIA (1, 13). How-
ever, evidence now suggests that Fc
 
g
 
RIIIB is able to medi-
ate intracellular signaling events, such as the activation of
the src family member hck and induction of intracellular
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1. 
 
Abbreviations used in this paper
 
: [Ca
 
2
 
1
 
]
 
i
 
, intracytoplasmic Ca
 
2
 
1
 
 concen-
tration; GPI, glycan phosphoinositol; ITAM, immunoreceptor tyrosine-
based activation motif; PLC, phospholipase C; PMN, polymorphonuclear
neutrophils.
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calcium fluxes (14, 19, 39, 49). Moreover, Fc
 
g
 
RIIIB coop-
erates with Fc
 
g
 
RIIA in PMN activation. When ligated to-
gether, as would occur when PMN bind immune complexes,
Fc
 
g
 
RIIA and Fc
 
g
 
RIIIB synergize to activate the respiratory
burst and to increase intracytoplasmic calcium (44, 47).
Despite the importance of the cooperation between
Fc
 
g
 
RIIA and Fc
 
g
 
RIIIB for PMN function, its mechanism
is not understood. As primary, terminally differentiated,
nondividing cells, PMN are exceedingly resistant to genetic
and cell biological manipulations which have aided charac-
terization of receptor function in other systems. We devel-
oped a model system to dissect the functional roles and do-
mains of Fc
 
g
 
RIIA and Fc
 
g
 
RIIIB in Jurkat T cells, which
lack endogenous Fc
 
g
 
 receptors but are fully competent for
tyrosine kinase signaling. In transfected Jurkat T cells, the
PMN Fc
 
g
 
 receptors synergized to induce a rise in intracy-
toplasmic Ca
 
2
 
1
 
 concentration ([Ca
 
2
 
1
 
]
 
i
 
) that was greater
and more prolonged than from ligation of either receptor
individually. This was identical to the effect of coligation
of these receptors in PMN (44). The synergistic calcium
rise required the influx of extracellular calcium and depended
upon the GPI anchor of Fc
 
g
 
RIIIB, since a mutant in which
the GPI anchor was replaced by the transmembrane
domain of CD7 was unable to synergize with Fc
 
g
 
RIIA.
Moreover, crosslinking other GPI-linked proteins on Jur-
kat T cells with Fc
 
g
 
RIIA also led to a synergistic increase
in [Ca
 
2
 
1
 
]
 
i
 
. The increase in [Ca
 
2
 
1
 
]
 
i
 
 also required the ty-
rosines of the Fc
 
g
 
RIIA ITAM. Surprisingly, we found
that phosphorylation of the ITAM was diminished under
conditions that led to the synergistic calcium flux and that
the kinetics of PLC-
 
g
 
1 phosphorylation was not altered by
the replacement of the GPI anchor of Fc
 
g
 
RIIIB with the
transmembrane domain of CD7. Thus, synergy between
Fc
 
g
 
R requires the GPI anchor of Fc
 
g
 
RIIIB, but not for an
increase in Fc
 
g
 
RIIA-dependent tyrosine kinase signaling.
We hypothesize instead that the role for the GPI anchor of
Fc
 
g
 
RIIIB is to sequester Fc
 
g
 
RIIA into specialized mem-
brane domains where signal transduction by the ITAM is
altered. This could provide a further level of modulation
of activation signals from immune complex binding and may
explain many of the functions of the unusual GPI-linked
Fc
 
g
 
R of primate PMN. Moreover, this could be a general
mechanism by which GPI anchored proteins affect signal
transduction from transmembrane receptors.
 
Materials and Methods
 
Cells and Antibodies
 
The human Jurkat T cells (American Type Culture Collection, Rockville,
MD) were maintained in RPMI 1640 medium (Gibco Laboratories,
Grand Island, NY) containing 10% heat-inactivated FCS (Hyclone, Lo-
gan, UT), 2 mM 
 
l
 
-glutamine, 0.1 mM NEAA, 50 mM 2-mercaptoethanol,
and 100 
 
m
 
g/ml penicillin and streptomycin under a 5% CO
 
2
 
 atmosphere.
The bulk population was cloned before transfection to minimize heteroge-
neity of the population. Human PMN were freshly purified from the pe-
ripheral blood of healthy donors as described (5). The following mAbs
were used in this study: IV.3 (anti-CD32, anti-Fc
 
g
 
RII; 26), 3G8 (anti-
CD16, anti-Fc
 
g
 
RIII; 9), IH4 (anti-CD55, anti-DAF; 8), MEM-43 (anti-
CD59, anti-Protectin), 10G10 (anti-CD59; kindly provided by Dr. Marilyn
Telen, Duke University, Durham, NC), MEM-102 (anti-CD48; Harlan
Bioproducts, Indianapolis, IN), II1A5 (anti-Fc
 
g
 
RII; kindly provided by
Dr. Jurgen Frey, Universität Bielefeld), and mouse IgG
 
2b
 
 isotype control
(Sigma Chemical Co., St. Louis, MO). To crosslink primary antibodies,
goat F(ab
 
9
 
)
 
2
 
 fragments specific for mouse F(ab
 
9
 
) or goat F(ab
 
9
 
)
 
2
 
 fragments
 
specific for mouse IgG
 
1
 
 or mouse IgG
 
2b
 
 (Sigma Chemical Co) were used.
Antibody fragments of IV.3, 3G8, or 10G10 were made by standard meth-
ods or purchased (Medarex, Annandale, NJ). For FACS
 
®
 
 analysis, bound
mAbs were detected using FITC-conjugated goat F(ab
 
9
 
)
 
2
 
 fragments spe-
cific for mouse F(ab
 
9
 
) (Sigma Chemical Co.). Anti-phospholipase C 
 
g
 
-1
(PLC-
 
g
 
1) was purchased from Upstate Biotechnology (Lake Placid, NY)
or Transduction Laboratories (Lexington, KY). Anti-phosphotyrosine
(Upstate Biotechnology) was detected with HRP-conjugated goat anti-
bodies specific for mouse IgG
 
2b
 
 (Caltag Laboratories, So. San Francisco, CA).
 
Fc
 
g
 
RIIA and Fc
 
g
 
RIIIB Expression Constructs and 
Transfection into Jurkat T Cells
 
The oligos 5
 
9
 
-CCTGAATTCCTCCGGATATCTTTGGTGAC-3
 
9
 
 and
5
 
9
 
-AGAGGATCCGCTGCCACTGCTCTTATTAC-3
 
9
 
 were used to am-
plify the human Fc
 
g
 
RIIIB (CD16) cDNA by RT-PCR of human PMN
mRNA (24). The resulting product was digested with EcoRI and HindIII
and ligated into similarly digested vectors, pBluescript II SK
 
1
 
/
 
2
 
, pRcCMV,
and pCEP4 (Invitrogen, San Diego CA). The intactness of the cDNA was
verified by DNA sequencing (ABI PRISM Dye Terminator Cycle Se-
quencing Ready Reaction Kit; Perkin Elmer, Foster City, CA). The Fc
 
g
 
-
RIIIB/CD7 construct was made by ligating a HindIII/MluI fragment of
the CD16/CD7/syk construct (kindly provided by Dr. Brian Seed, Harvard
Medical School, Boston, MA; (20) and a MluI/NotI adaptor (annealed oli-
gonuclotides 5
 
9
 
-CGCGTTAATAGATCGATGC-39 and 59-GGCCGCAT-
CGATCTATTAA-39 [stop codons underlined]) into HindIII/NotI-digested
pRcCMV. This construct encodes the FcgRIIIB extracellular domain
joined with a CD7 transmembrane domain. The cDNA was verified by
DNA sequencing. The cDNAs encoding FcgRIIA and FcgRIIA with both
ITAM tyrosines in the cytoplasmic tail mutated to phenylalanine were pre-
pared as described (7, 27) and cloned into pRcCMV and pCEP4.
The resulting plasmids were introduced into clones of Jurkat T cells by
electroporation. Cells (107) in 400 ml HEBS (25 mM Hepes, pH 7.05, 140 mM
NaCl, 750 mM Na2HPO4) and plasmid (30 mg in 100 ml HEBS) were
added to a 0.4-mm-gap width cuvette and electroporated at 1,000 mF, 330 v
(Electroporator II; Invitrogen). After electroporation, cells were cultured
for 36 to 48 h in normal propagation media. Cells were transferred to se-
lective media (propagation media plus 1.4 mg/ml geneticin/G418 [Gibco
Laboratories] and/or 600 mg/ml hygromycin B [Boehringer Mannheim, In-
dianapolis, IN]) and cultured for 2 to 3 wk. High protein-expressing cell
populations were selected by fluorescence-activated cell sorting using
mAb IV.3 or mAb 3G8. Briefly, cells (106) were resuspended in 50 ml
PBS/5% FCS with 1 mg antibody and incubated on ice for 45 min. Cells
were washed and then incubated an additional 30 min with F(ab9)2 frag-
ments of goat anti–mouse IgG-FITC (Sigma Chemical Co.). Cells were
analyzed on a flow cytometer (Coulter Electronics, Hialeah, FL) or sorted
using a fluorescence-activated cell sorter (Becton Dickenson, Palo Alto,
CA). All cDNAs were introduced into at least two different Jurkat clones
and all experiments yielded equivalent results in all clones.
[Ca21]i Measurements
Jurkat transfectants were loaded with 3 mM Fura 2-AM (Molecular
Probes, Eugene, OR) in RPMI 1640/10% FCS for 40 min in the dark at
378C. PMN were loaded with 5 mM Fura-2 AM in Hanks Balanced Salt
Solution (HBSS; Gibco Laboratories), 1 mM MgCl2, 1 mM CaCl2, and 1%
vol/vol human serum albumin (HBSS11) for 25 min in the dark at 378C.
Cells (6 3 106) were washed once, resuspended in RPMI 1640/10% FCS
or HBSS11 containing the appropriate mAbs, and incubated 30 min on
ice. Cells were washed three times and resuspended in 2 ml calcium buffer
(25 mM Hepes, pH 7.4, 125 mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 1 mg/ml
d-glucose, 1 mg/ml BSA, 1 mM CaCl2, 0.5 mM MgCl2). Changes in fluo-
rescence, using excitation wavelengths of 340 and 380 nm and the emission
wavelength of 510 nm, were measured with a spectrofluorimeter (F-2000;
Hitachi Instruments, Danbury, CT) equipped with a thermostatic cuvette
holder maintained at 378C. Cells were warmed to 378C for 5 min and
added to the cuvette; then 10 ml mouse F(ab9) specific goat F(ab9)2 frag-
ments were added. Intracellular calcium concentrations were calculated as
described (36).
Receptor Crosslinking, Immunoprecipitation, and 
Western Blots
Cells (1–2 3 107) were incubated in RPMI 1640/10% FCS containing the
mAb IV.3 (15 mg/ml) or the mAbs IV.3 and 3G8 (15 mg/ml each) for 30Green et al. GPI Anchor in FcgR Cooperation 1211
min on ice. Cells were washed three times, resuspended in 0.5 ml RPMI
1690 with 10% FCS, and then warmed to 378C for 10 min. Crosslinking
mouse F(ab9) specific goat F(ab9)2 fragments (20 ml) were added for vari-
ous times. Cells were lysed with an equal volume of 23 lysis buffer (100 mM
Tris-HCl, pH 7.4, 2% NP-40, 0.5% deoxycholate, 300 mM NaCl, 2 mM
EDTA, 2 mM NaF, 250 mM Na3VO4, 1 mM Na2MoO4, 1 mM Na2H2P2O7,
10 ng/ml calyculin, 25 mg/ml aprotinin, 25 mg/ml leupeptin, 15 mg/ml pep-
statin A, 1 mM phenylmethylsulfonyl fluoride) at 48C. Samples were cen-
trifuged 5 min at 14,000 g. Resulting supernatants were rotated overnight
with 75 ml of a 1:1 slurry of Gamma Bind plus Sepharose (Pharmacia Bio-
tech, Piscataway, NJ). For PLC g-1 immunoprecipitations, 10 ml of poly-
clonal antibodies were added to each sample. Beads were washed exten-
sively and resuspended in reducing cocktail (50% vol/vol glycerol, 250 mM
Tris-HCl, pH 6.8, 5% wt/vol SDS, 570 mM 2-mercaptoethanol, bromphe-
nol blue). Samples were boiled for 5 min and then subjected to SDS-
PAGE and electrotransfer onto Immobilon-P (Milipore, Bedford, MA)
membranes. Blots were probed with anti-phosphotyrosine, anti-FcgRII
(II1A5), or anti-PLC g-1. Bound antibodies were detected with HRP-con-
jugated mouse specific goat antibodies. Antibody reactive protein was vi-
sualized using enhanced chemiluminescence (ECL; Amersham Intl., Ar-
lington Heights, IL). Tyrosine phosphorylation of FcgRIIA or PLC-g1
under different conditions was compared by normalizing the amount of
phosphorylation, determined by densitometry of the anti-phosphotyrosine
blots, to the amount of protein precipitated, as determined by reprobing
the same blots with antibodies to the relevant protein. Multiple experi-
ments were combined for analysis by comparing all experimental condi-
tions to the ratio obtained for wild-type receptors in the same experiment.
Results
Cocrosslinking FcgRIIA and FcgRIIIB Results in a 
Synergistic [Ca21]i Rise
Jurkat T cells, which do not express endogenous Fcg re-
ceptors, were stably transfected with the cDNAs encoding
FcgRIIA and FcgRIIIB (J2/3; Fig. 1, top). In addition, sta-
ble transfectants were made which express FcgRIIA along
with a chimeric receptor consisting of the extracellular
portion of FcgRIIIB coupled to the transmembrane do-
main of CD7 (J2/3-CD7; Fig. 1, middle). A third transfec-
tant was made that expresses FcgRIIIB and an FcgRIIA
receptor in which the tyrosines (Y282 and Y298) of the
ITAM have been mutated to phenylalanines (27; J2Y®
F/3, Fig. 1, bottom). FACS® analysis indicated that each
mutant receptor is expressed at a level at least comparable
to that of the corresponding wild-type receptor (Fig. 1).
Previous studies in PMN have shown that FcgRIIA and
FcgRIIIB in PMN cooperate to generate a calcium flux
that is greater than the sum of the calcium fluxes gener-
ated by crosslinking either receptor individually (44). In
addition, it has been shown that Jurkat cells that were sta-
bly transfected with FcgRIIA are able to flux calcium after
receptor ligation (15), suggesting the signaling machinery
used by Fcg receptors is functional in these cells. There-
fore we compared [Ca21]i in J2/3 cells after crosslinking
FcgRIIA and FcgRIIIB individually or after crosslinking
both receptors together, using a F(ab9)2 crosslinking anti-
body. Crosslinking FcgRIIA resulted in a significant, short
lived rise in [Ca21]i (Fig. 2, top). In contrast, crosslinking
FcgRIIIB alone resulted in a slow rise in [Ca21]i with a
magnitude lower than for FcgRIIA (Fig. 2, top). When
both FcgR were crosslinked together, there was an in-
crease in the maximum [Ca21]i rise and a prolongation of
the increase (Fig. 2, top). Synergy did not require the Fc
fragment of either anti-FcgRII or -FcgRIII mAb, since
similar results were obtained by using the F(ab) fragment
of the mAb IV.3 and the F(ab9)2 fragment of the mAb
3G8 (data not shown). Neither the addition of antibodies
specific for Fcg receptors alone nor the crosslinking goat
F(ab9)2 fragments alone induced a rise in [Ca21]i (Fig. 2,
top and data not shown). In PMN, crosslinking FcgRIIIB
is able to mediate a rise in intracellular calcium by itself.
This difference between the Jurkat transfectants and PMN
is most likely due to the level of FcgRIIIB expression. In
PMN, FcgRIIIB is extremely abundant on the cell surface
(12, 13). Phosphatidylinositol-specific phospholipase C
(PLC) treatment of PMN, an enzyme that cleaves GPI-
linked proteins and that removes 80% of the FcgRIIIB
from the cell surface, abolishes the rise in [Ca21]i after
FcgRIIIB crosslinking (35, and data not shown). Nonetheless,
the expression level of FcgRIIIB in the transfected Jurkat
cells was sufficient to produce a synergistic rise in [Ca21]i.
To determine if the synergistic calcium response re-
quired bridging of FcgRIIA and FcgRIIIB together or
whether the augmentation in [Ca21]i could be achieved by
simultaneously crosslinking each Fcg receptor individu-
ally, isotype-specific secondary crosslinking antibodies were
used (Fig. 2, middle). FcgRIIA was crosslinked with IV.3,
an IgG2b mAb, and goat F(ab9)2 fragments specific for
mouse IgG2b and FcgRIIIB was crosslinked with 3G8, an
IgG1 mAb, and goat F(ab9)2 fragments specific for mouse
IgG1. When both Fcg receptors were individually and si-
multaneously crosslinked, no synergistic rise in [Ca21]i was
found (Fig. 2, middle), paralleling results found in PMN
(44). In fact, the resulting rise in [Ca21]i appeared to be ad-
ditive of the rises obtained by crosslinking both Fcg recep-
tors individually (Fig. 2, middle).
To show specificity of the synergy, cells were incubated
Figure 1. Fluorescent flow cy-
tometric analysis of FcgR ex-
pression. Jurkat T cells (106)
expressing various Fcg re-
ceptors were resuspended in
50 ml PBS/5% FCS with 1 mg
of the mAb IV.3 (2), specific
for FcgRIIA, mAb 3G8 (3),
specific for FcgRIIIB, or the
mAb MEM-43 (4), specific
for CD59. Cells were also
stained with a negative con-
trol antibody (1). Cells were
washed and then stained with
F(ab9)2 fragments of FITC-
conjugated goat anti–mouse
antibodies and then analyzed
by FACS®. Cells expressing
wild-type FcgRIIA and Fcg-
RIIIB (J2/3; top), wild-type
FcgRIIA and the chimeric
FcgRIIIB/CD7 (J2/3-CD7;
middle), or wild-type Fcg-
RIIIB and the mutant Fcg-
RIIA where the tyrosines
within the ITAM (Y282 and
Y298) are changed to phenyl-
alanine (J2Y®F/3; bottom)
are shown.The Journal of Cell Biology, Volume 139, 1997 1212
with anti-FcgRII mAb IV.3 and the mAb IB4, specific for
b2 (CD18) integrins (Fig. 2, bottom). The b2 integrin
LFA-1 is expressed at a level similar to the transfected
FcgRIIIB (data not shown). Moreover, LFA-1 synergizes
with the ITAM-containing T cell antigen receptor to pro-
long an increase in [Ca21]i (45). However, there was no
synergy between LFA-1 and FcgRIIA for [Ca21]i rise.
This result indicates that signaling through FcgRIIA is
augmented when cocrosslinked to FcgRIIIB, as would oc-
cur under physiological conditions where both Fcg recep-
tors are ligated by immune complexes.
The GPI Anchor Is Necessary and Sufficient for the 
Contribution of FcgRIIIB to Synergy
Primate PMN are the only cells that express a GPI-anchored
Fcg receptor (32). To determine whether the GPI anchor
was necessary for FcgRIIIB contribution to the synergistic
increase in [Ca21]i, stable transfectants were made ex-
pressing FcgRIIA and a chimeric FcgRIIIB with the GPI
anchor replaced by the transmembrane domain of CD7
(J2/3-CD7; Fig. 1, middle). When FcgRIIA and FcgRIIIB/
CD7 were crosslinked together in these cells, the [Ca21]i
rise was similar to the rise generated when FcgRIIA was
crosslinked alone without any synergy from FcgRIIIB
(Fig. 3, middle). The inability of the chimeric FcgRIIIB/
CD7 molecule to contribute to the synergistic [Ca21]i rise
was not due to inadequate expression of this protein, since
the FcgRIIIB/CD7 molecule was expressed at a greater
level than the wild-type FcgRIIIB (Fig. 1, top and middle).
This experiment demonstrates that the GPI anchor is nec-
essary for the synergistic [Ca21]i rise.
To determine whether any aspect of the extracellular Ig
domains of FcgRIIIB rise were required for the synergistic
[Ca21]i rise, other GPI-linked proteins expressed by Jurkat
cells were cocrosslinked with FcgRIIA. CD48 (not shown)
and CD59 (protectin) (Fig. 1) are both expressed by paren-
tal Jurkat cells and by each of the transfectants at levels
equal to or greater than FcgRIIIB. When these GPI-linked
proteins, CD59 (Fig. 3, top) and CD48 (not shown), were
cocrosslinked with FcgRIIA, a synergistic rise in [Ca21]i
also occurred in Jurkat cells transfected with FcgRIIA alone
(data not shown), in J2/3 cells (Fig. 3, top), and in J2/3-
CD7 cells (Fig. 3, middle). In all of these cells, ligation of
CD59 alone produced a [Ca21]i rise similar to that elicited by
crosslinking FcgRIIIB alone (Fig. 3, top, and data not shown).
These experiments demonstrate that the GPI anchor of
FcgRIIIB is required for FcgR cooperation but that other
extracellular domains will substitute for FcgRIIIB when
cocrosslinked with FcgRIIA. This is strong evidence against
the hypothesis that interaction between the extracellular
domains of the receptors is required for synergy, as has
been proposed for FcgRIIA and FcgRIIIB interaction
with the b2 integrin CR3 (for review see 30). Moreover,
since these cells do not express CR3, this experiment shows
that FcgR synergy can occur without this PMN integrin.
Synergy in PMN between FcgRIIA and FcgRIIIB was
found for the rise in [Ca21]i (data not shown and 44), the
respiratory burst (data not shown and 44, 47, 49), and de-
granulation (data not shown). To determine if the syner-
gistic rise in [Ca21]i could also be obtained in PMN with
other GPI-anchored proteins, FcgRIIA and CD59 were
cocrosslinked and a prolongation in the rise [Ca21]i was
found (Fig. 3, bottom). The synergistic rise in [Ca21]i with
FcgRIIA and CD59 was not as pronounced as with FcgRIIIB
and FcgRIIA. No significant synergy between FcgRIIA
and CD59 was found in assays of degranulation or respira-
tory burst. This was true for CD48, CD55, and CD66b,
other GPI-linked proteins on PMN, as well (data not shown).
This is most likely due to a lower level of expression of
these GPI-anchored proteins on PMN as compared to
FcgRIIIB (CD59 has z13% of the expression of FcgRIIIB,
CD48 has 1%, CD55 has 6%, and CD66b has 9%; data not
shown). This is consistent with the lack of a synergistic rise
in [Ca21]i obtained in PMN treated with phosphatidylino-
sitol-specific PLC, which reduces the amount of FcgRIIIB
on the cell surface by 80% (35 and data not shown).
The ITAM of FcgRIIA Is Required for Calcium Flux
Activation of tyrosine phosphorylation and propagation of
Figure 2. Changes in the [Ca21]i after crosslinking FcgR. Fura 2-AM
pre-loaded J2/3 cells were incubated 30 min with the mAb IV.3
(anti-FcgRII, IgG2b), the mAb 3G8 (anti-FcgRIIIB, IgG1), or
both these mAbs (top and middle). J2/3 cells also were incubated
with mAb IV.3 and the mAb IB4, specific for b2 integrins (bot-
tom). F(ab9)2 fragments of goat anti–mouse antibodies (top and
bottom), F(ab9)2 fragments of goat anti–mouse IgG1 (middle), or
F(ab9)2 fragments of goat anti–mouse IgG2b (middle) were added
to crosslink Fcg receptors at 20 s. Each curve is representative of
at least three independent experiments. When FcgRIIA was
crosslinked with mAb IV.3/anti-IgG1 or FcgRIIIB was crosslinked
with mAb 3G8/anti-IgG2b, no rise in [Ca21]i resulted, demonstrat-
ing specificity of the secondary antibodies (data not shown). No
rise in [Ca21]i resulted from the addition of secondary antibodies
alone (data not shown).Green et al. GPI Anchor in FcgR Cooperation 1213
a tyrosine kinase cascade by receptor associated ITAMs is
thought to be essential for Fcg receptor signaling (16, 43).
To determine whether this cascade had a role in Fcg re-
ceptor synergy, Jurkat cells were transfected with FcgRIIIB
and a mutant FcgRIIA in which tyrosines Y282 and Y298
contained within the ITAM were mutated to phenylalanines
(J2Y®F/3; Fig. 1, bottom). It has been shown in model
systems that these tyrosines are required for [Ca21]i flux
when FcgRIIA is ligated alone (27, 28). No synergistic
[Ca21]i flux occurred in J2Y®F/3 cells when FcgRIIA was
ligated either alone or together with FcgRIIIB, although
these cells were fully competent to increase [Ca21]i in re-
sponse to antigen receptor ligation (Fig. 4). Therefore,
these tyrosines in the cytoplasmic tail of FcgRIIA are re-
quired for the synergistic [Ca21]i rise. Thus both the GPI
anchor of FcgRIIIB and the ITAM motif of FcgRIIA are
required for synergy in calcium signaling.
The Synergistic Signal Does Not Result in Increased 
Tyrosine Phosphorylation of FcgRIIA
Because of the requirement for the ITAM in synergy and
the association of GPI-linked proteins with src family ki-
nases (4, 43), we hypothesized that an early step in this
synergistic interaction might be an increased tyrosine
phosphorylation of the ITAM of FcgRIIA. When FcgRIIA
was immunoprecipitated from J2/3 cells after crosslinking
FcgRIIA alone, its tyrosine phosphorylation peaked at 1
min and was diminished by 5 min (Fig. 5 A, top). Surpris-
ingly, crosslinking FcgRIIA and FcgRIIIB together did
not enhance tyrosine phosphorylation of FcgRIIA as ex-
pected but actually diminished detection of the tyrosine
phosphorylation of FcgRIIA (Fig. 5 A, top). Averages from
three experiments after normalization for the amount of
receptor immunoprecipitated showed that FcgRIIA was
phosphorylated z10-fold less under synergistic conditions
as compared to ligation of FcgRIIA alone. We also ana-
lyzed the tyrosine phosphorylation of FcgRIIA in J2/3-CD7
cells. Ligation of FcgRIIA without FcgRIIIB induced ty-
rosine phosphorylation of itself to a similar extent and
with similar kinetics as in cells expressing both wild-type
Fcg receptors (Fig. 5 B, bottom). In striking contrast to the
results obtained in J2/3 cells by crosslinking both wild-type
Fc receptors, cocrosslinking FcgRIIA and FcgRIIIB/CD7
did not significantly diminish the extent or alter the kinet-
ics of FcgRIIA phosphorylation (Fig. 5 A, bottom). To de-
termine if the marked diminution of FcgRIIA tyrosine phos-
phorylation also occurred when it was crosslinked with
other GPI-anchored proteins, FcgRIIA was crosslinked
with CD48 or CD59 (Fig. 5 B). Cocrosslinking any GPI-
anchored protein with FcgRIIA markedly diminished its
tyrosine phosphorylation. In addition, we analyzed the ex-
tent of tyrosine phosphorylation of FcgRIIA in PMN after
ligating FcgRIIA, individually or together with FcgRIIIB,
by using the F(ab) fragment of mAb IV.3 and the F(ab9)2
of mAb 3G8. Crosslinking both Fcg receptors resulted in
z2–3-fold diminished tyrosine phosphorylation of FcgRIIA
when compared to ligating FcgRIIA alone (data not shown).
The Synergistic Calcium Rise Does Not Result from the 
Prolonged Tyrosine Phosphorylation of PLC-g1
PLC-g1 is one of several PLC isoforms that converts phos-
phatidylinositol 4,5-bisphosphate to diacylglycerol and inosi-
Figure 3. [Ca21]i in cells expressing the chimeric FcgRIIIB/CD7.
J2/3 cells (top), J2/3-CD7 cells (middle), or PMN (bottom) were
preloaded with Fura 2-AM. J2/3 and J2/3-CD7 cells were then in-
cubated for 30 min with the mAb IV.3 (anti-FcgRII), mAb 3G8
(anti-FcgRIII), mAb MEM-43 (anti-CD59), or combinations of
these mAbs. PMN were incubated with mAb IV.3 F(ab), mAb
10G10 F(ab9)2 (anti-CD59), or combinations of these mAbs. Ex-
periments were performed as described in Fig. 2. Each curve is
representative of at least three independent experiments. For
PMN, the change in [Ca21]i at 140 s after the addition of cross-
linking antibody was calculated and results are shown as the
mean  6 SEM for three independent experiments (bottom).
Figure 4. [Ca21]i flux in cells expressing FcgRIIA containing the
ITAM mutation. Fura 2-AM preloaded J2Y®F/3 cells were incu-
bated with the mAbs IV.3 (anti-FcgRII) and 3G8 (anti-FcgRIII),
then analyzed by fluorimetry as described in Fig 2. The mAb
C305, specific for the TCR/CD3 complex, was added at 300 sec to
demonstrate that these cells are competent to flux [Ca21]i.The Journal of Cell Biology, Volume 139, 1997 1214
tol 1,4,5-triphosphate leading to the release of intracellular
stores of calcium. In several cell types, crosslinking FcgRIIA
induces the tyrosine phosphorylation of PLC-g1, which
leads to its activation (25, 42). To determine whether pro-
longed activation of PLC-g1 could account for the syner-
gistic increase in [Ca21]i, its tyrosine phosphorylation was
examined. In agreement with previous studies, crosslink-
ing FcgRIIA in the transfected Jurkat cells resulted in ty-
rosine phosphorylation of PLC-g1 that was visible by 1 min
(data not shown, and 42). Crosslinking FcgRIIIB and Fcg-
RIIA in J2/3 cells resulted in tyrosine phosphorylation of
PLC-g1, which was not different from cocrosslinking Fcg-
RIIA and the chimeric FcgRIIIB/CD7 in J2/3-CD7 cells
(Fig. 6). Thus, Fcg receptor synergy is independent of the
tyrosine phosphorylation of PLC-g1.
The Synergistic Rise in [Ca21]i Requires the Influx of 
Extracellular Calcium
To determine the source of Ca21 for the synergistic [Ca21]i
rise in the J2/3 cells, changes in Fura-2 fluorescence were
measured in the presence of extracellular EGTA to pre-
vent calcium influx from the medium. The synergistic [Ca21]i
rise was inhibited almost immediately after addition of
EGTA, indicating that calcium influx through plasma mem-
brane channels is largely responsible for the prolonged
[Ca21]i rise (Fig. 7 A, left) as found in PMN (44). Similarly,
the synergistic [Ca21]i rise induced by cocrosslinking
FcgRIIA and CD59 was abolished by the addition of
EGTA (Fig. 7 A, middle). As a control, the changes in in-
tracellular calcium were measured after the T-cell recep-
tor complex (TCR/CD3) was crosslinked with the mAb
C305 (Fig. 7 A, right). Previous studies have shown that
the rise in intracellular calcium after TCR crosslinking re-
sults from an initial rise derived from intracellular stores
followed by a secondary sustained calcium influx through
plasma membrane channels that can be abolished by the
addition of EGTA (41). The addition of EGTA to Jurkat
cells treated only with crosslinking secondary antibody
does cause a small decrease in the amount of intracellular
calcium, but this small depletion does not account for the
large loss in the synergistic calcium influx from extracellu-
lar stores, as previously shown in PMN (37; Fig. 7, A and
C, left). The changes in intracellular calcium also were
measured when EGTA was added immediately before
Fcg receptor crosslinking (Fig. 7 B, left). Crosslinking led
to an initial rise in [Ca21]i, but the synergistic [Ca21]i rise
was substantially diminished after cocrosslinking FcgRIIA
with FcgRIIIB or CD59 (Fig. 7 B, middle and right). The
magnitude of the [Ca21]i rise also was diminished in the
presence of EGTA, again demonstrating that a significant
contribution to the [Ca21]i rise is due to the influx of extra-
cellular calcium (Fig. 7 B). The slow rise in [Ca21]i after
crosslinking either FcgRIIIB or CD59 alone was abolished
in the presence of EGTA (Fig. 7 C, right, and data not
shown). EGTA treated cells do not produce a flux in
[Ca21]i after the addition of crosslinking secondary anti-
bodies alone (Fig. 7 C, left).
Discussion
Since the discovery that GPI-linked proteins can transduce
proliferative signals, attention has focused on the mecha-
nism by which these proteins, anchored into the outer leaf-
let of the plasma membrane by their fatty acyl chains, can
signal to the cell cytoplasm. Two distinct but not mutually
exclusive paradigms have developed. One model suggests
that GPI-linked proteins can sequester into specialized
Figure 5. Tyrosine phosphorylation of FcgRIIA after crosslink-
ing FcgR. (A) J2/3 (top) or J2/3-CD7 (bottom) cells were incu-
bated with mAb IV.3 (anti-FcgRII) or with mAbs IV.3 and 3G8
(anti-FcgRIII) for 30 min on ice and then warmed 10 min to 378C.
(B) J2/3 cells were incubated with various combinations of mAbs
specific for FcgRII, FcgRIII, CD48, or CD59. In both panels,
crosslinking F(ab9)2 fragments of goat anti–mouse antibodies
were added for various amounts of time. At each time point, an
aliquot was removed, lysed, and FcgRIIA immunoprecipitated.
Proteins were separated by SDS-PAGE, and blots were probed
with anti-phosphotyrosine. Cocrosslinking of GPI- but not trans-
membrane-anchored FcgRIIIB diminishes tyrosine phosphoryla-
tion of FcgRIIA. Blots shown are representative of at least five
experiments.
Figure 6. The tyrosine phosphorylation of PLC-g1 after cross-
linking various FcgR. J2/3 (squares) or J2/3-CD7 (triangles) cells
were incubated with mAbs IV.3 (anti-FcgRII) and 3G8 (anti-
FcgRIII), warmed to 378C, and crosslinking initiated by addition
of F(ab9)2 fragments of goat anti–mouse antibodies. At each time
point, an aliquot was removed, PLC-g1 was immunoprecipitated,
and proteins were separated by SDS-PAGE. Blots were probed
with anti-phosphotyrosine and subsequently with anti–PLC-g1
antibodies to determine the relative phosphorylation of the im-
munoprecipitated enzyme, as described in Materials and Meth-
ods. Three independent experiments from both cell types were
analyzed by densitometry, and the mean and SEM of the three
experiments are shown.Green et al. GPI Anchor in FcgR Cooperation 1215
membrane domains, especially after clustering (for review
see 29, 34). These domains, which are defined by their in-
solubility in Triton X-100, contain characteristic lipid com-
ponents, such as glycosphingolipids and cholesterol, but
may be depleted in certain phospholipids. GPI-linked pro-
teins are enriched z200-fold in these domains, and there is
evidence for concentration of Src kinases, G protein–cou-
pled receptors, and heterotrimeric G proteins in these
membrane domains as well. This has led some investiga-
tors to hypothesize that these domains function in signal
transduction, and indeed crosslinking of GPI-linked pro-
teins leads to rapid induction of tyrosine phosphorylation
(43). On the other hand, some src family kinases seques-
tered in these domains have low specific activity, suggest-
ing that these glycolipid domains function not in signaling
but as a reservoir of signaling molecules that can be re-
cruited to other parts of the membrane (34).
The second model for signal transduction by GPI-linked
proteins involves their physical association with transmem-
brane proteins. For example, FcgRIIIB has been shown to
associate with the integrin Mac-1, as has the GPI-linked
urokinase receptor (uPAR), which also can associate with
another integrin, avb3 (21, 46). These physical associa-
tions have functional consequences, for example, induc-
tion of IgG-mediated phagocytosis in transfected 3T3 cells
(21), or cellular adhesion to vitronectin (46). Thus, it is
possible that GPI-linked proteins transduce information
to the cytoplasm through physical interaction with trans-
membrane proteins.
The interaction of FcgRIIA and FcgRIIIB on human
PMN presents an opportunity to test these hypotheses
concerning signal transduction by GPI-linked proteins.
When immune complexes bind to PMN, FcgRIIA and
FcgRIIIB are brought into proximity. While synergy be-
tween the receptors in signal transduction in response to
immune complexes has been shown, interpretation is com-
plicated by the interaction of both receptors with other
membrane proteins such as Mac-1 (40, 48), and by the in-
ability to use molecular genetic techniques to probe recep-
tor function in these primary cells. For these reasons, we
have developed a model system to understand Fcg receptor
synergy on PMN. In Jurkat cells without Mac-1, FcgRIIA
and FcgRIIIB can synergize to increase [Ca21]i, demon-
strating that extracellular domain association with Mac-1
Figure 7. The synergistic rise in [Ca21]i requires the influx of extracellular calcium. Changes in Fura 2-AM fluorescence after receptor
crosslinking in J2/3 cells was measured as in Fig. 2 in the absence or presence of 2 mM EGTA to prevent calcium influx from the me-
dium. (A) 2 mM EGTA was added 280 s after crosslinking. (B) 2 mM EGTA was added immediately before receptor crosslinking. Also
shown is no added EGTA. (C) 2 mM EGTA was added at 0 or 300 s.The Journal of Cell Biology, Volume 139, 1997 1216
is not required for at least this aspect of synergy. Indeed,
since coligation of two other GPI-linked proteins, other-
wise structurally unrelated to FcgRIIIB, also can synergize
with FcgRIIA to increase [Ca21]i, it is unlikely that extra-
cellular domain interactions other than with multivalent
ligands are required to induce synergy between the trans-
membrane and GPI-linked Fcg receptors. The synergistic
increase in [Ca21]i may be important in numerous PMN
functions, including degranulation (3, 23), actin polymer-
ization (2), and phagocytosis (17, 18).
Our data support the hypothesis that association of
FcgRIIA with glycolipid domains enriched in GPI-linked
proteins fundamentally alters subsequent signaling. Co-
crosslinking FcgRIIA with any of the GPI-linked proteins
induced the synergistic increase in [Ca21]i and, surprisingly,
decreased the extent of FcgRIIA tyrosine phosphoryla-
tion. When FcgRIIIB was expressed with a transmem-
brane domain, its synergy with FcgRIIA was abolished, as
was its effect on FcgRIIA tyrosine phosphorylation. These
data support the hypothesis that the membrane environ-
ment of FcgRIIA is altered by crosslinking it with GPI-
anchored proteins. This altered environment modulates
the FcgRIIA-generated signal in fundamental ways. We
initially expected that the synergistic [Ca21]i rise would be
associated with increased phosphorylation of the ITAM of
FcgRIIA, because src family kinases, which phosphorylate
ITAMs, have been found to be concentrated in these do-
mains. However, our finding of decreased tyrosine phos-
phorylation is consistent with the report that CD45, the
major transmembrane tyrosine phosphatase present on
lymphocytes, is excluded from glycolipid-enriched mem-
brane domains, resulting in lower specific activity of the
lymphocyte src kinases in these domains (34). We propose
that FcgRIIA has diminished tyrosine phosphorylation af-
ter cocrosslinking with FcgRIIIB, because ligation with
GPI-linked proteins causes FcgRIIA to be brought into
membrane domains with less-active src kinases. It is also
possible that an additional signaling pathway is used to
mediate synergistic calcium signaling, since the prolonged
rise in intracellular calcium is not due to the prolonged ty-
rosine phosphorylation of PLC-g1. Calcium mobilization
after crosslinking FceRI activates a sphingosine kinase
that produces sphingosine-1-phosphate as a second mes-
senger for intracellular calcium mobilization (6). Alterna-
tively, localization of the Fcg receptors within specialized
membrane domains may activate the synergistic influx of
extracellular calcium. Indeed, a plasma membrane calcium
pump has been identified in caveolae (10).
Our data further extend the observations made with
several receptors, including Fcg receptors, that there may
be interaction on the cell surface between receptors recog-
nizing the same ligand. For example, T cells express two
distinct receptors that interact with MHC class I mole-
cules, one that mediates the positive signal, the T cell re-
ceptor, and a second receptor, NKB1, that mediates an in-
hibitory signal (22, 31). It has been observed in phagocytic
cells that the Fcg receptor, FcgRIIB, inhibits phagocytosis
mediated by FcgRIIA. Decreased tyrosine phosphoryla-
tion induced by FcgRIIB after interaction with IgG ligand
may be responsible for this inhibition of FcgRIIA-medi-
ated phagocytosis (Hunter, S., and A.D. Schreiber, unpub-
lished results).
In summary, transfection of human PMN Fcg receptors
into the Jurkat cell line has allowed for the further dissec-
tion of the mechanism by which these receptors cooperate
in immune complex–induced PMN activation. We have de-
fined two essential structural components of the synergis-
tic signal, the GPI-anchor of FcgRIIIB and the ITAM of
FcgRIIA. Moreover, we have shown that synergy can oc-
cur in the absence of the phagocyte integrin Mac-1, previ-
ously postulated to be an essential component for synergy.
In PMN, 10,000 to 20,000 FcgRIIA molecules are ex-
pressed on the cell surface together with 10 to 20 times
more FcgRIIIB (12, 13). Thus it is highly likely that when-
ever FcgRIIA is ligated by an immune complex, it is in as-
sociation with several GPI-linked FcgRIIIB and that the
modulated signal which occurs because of association with
GPI domains is the major mechanism of immune complex-
mediated PMN activation.
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